Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Funxional Therapeutics

Request full access

Novel small molecule anti-inflammatory therapies development

Cambridge, United KingdomFounded 2005Biotech & Life Sciences

About Funxional Therapeutics

Funxional Therapeutics Ltd (FXT) was a privately held, clinical-stage pharmaceutical company based in Cambridge, UK, that focused on developing novel anti-inflammatory therapies. The company was founded in 2005 by Dr. David Grainger, based on intellectual property he and his colleagues developed at Cambridge University. Grainger, who spent 15 years leading a laboratory at the university, served as the Chief Scientific Officer.

The company's primary business was the discovery and development of a new class of anti-inflammatory small molecules called somatotaxins. These molecules exploit a novel pathway acting through the type-2 somatostatin receptor to resolve inflammation, which is disrupted in chronic diseases like asthma, COPD, and rheumatoid arthritis. Their lead product was FX125L, an orally available, once-daily small molecule that had completed Phase I studies and was in Phase II trials at the time of the company's acquisition. The business model was asset-centric, focusing on advancing its lead compounds through clinical trials to prove their value for acquisition by a larger pharmaceutical company.

In July 2012, Boehringer Ingelheim, a leading global pharmaceutical company, acquired the worldwide rights to Funxional Therapeutics' FX125L compound and its entire somatotaxin program. Boehringer Ingelheim took over all further research, development, and commercialization responsibilities, intending to develop the therapy for respiratory diseases such as Asthma and COPD. The acquisition represented a successful exit for Funxional's investors, which included Index Ventures, Novo A/S, and Ventech. Following the sale, Funxional Therapeutics ceased operations.

Source: Dealroom company data

At a glance

Status
Operational
Open positions
None listed
Dealroom signal
24.7/100
Industry
Health
Sub-industry
Pharmaceutical
Sector
Biotechnology, Spinout, Biotech and Pharma, DT and LS, uk is8 life sciences, science-based
Business model
Manufacturing
Client focus
B2B
Links
Website

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES B✓Equity / VC May 2010 $12M $49M Ventech · Medicxi · Novo Ventures —
SERIES A✓Equity / VC Jan 2006 $0 — Novo Ventures · Medicxi —
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Funxional Therapeutics website traffic

Latest recorded traffic for Funxional Therapeutics is 0 monthly website visits.

Latest monthly visits0
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Funxional Therapeutics in the Cambridge ecosystem

Live from Dealroom

The Funxional Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

4 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

  • Novo Ventures
  • Medicxi
  • Ventech

Other known investors1 additional known investor

  • University of Cambridge
Team profiled 5 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇬🇧 United Kingdom · Cambridge HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Funxional Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Funxional Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.